|
|
||||||||
Journal of Lipid Research, Vol 36, 1557-1566, Copyright © 1995 by Lipid Research, Inc.
F Karpe and M Hultin
The rat liver secretes very low density lipoproteins (VLDL) containing
either apoB-100 or apoB-48. After oral fat intake, chylomicrons containing
apoB-48 and endogenously synthesized VLDL are mixed in the blood and the
triglyceride clearance from these triglyceride-rich lipoprotein species
compete for the same lipolytic pathway, i.e., lipoprotein lipase. A
situation mimicking alimentary lipemia was induced by a short-term
intravenous primed infusion of a chylomicron- like triglyceride emulsion to
fed and fasted rats. The plasma concentration of apoB-100 and apoB-48 was
monitored in triglyceride- rich lipoprotein subfractions after separation
with density gradient ultracentrifugation by analytical SDS-PAGE. The net
liver secretory output of VLDL was quantified by lipolytic blockade induced
by Triton WR 1339. The chylomicron-like triglyceride emulsion induced a
linear increase of large VLDL (Sf 60-400 subfraction containing both
apoB-100 and apoB-48), almost to the same extent as that induced by Triton.
The clearance of postprandial triglyceride-rich lipoproteins and both
lipolysis and clearance of intravenously injected labeled rat chylomicrons
was efficiently inhibited by the emulsion but not so complete as for
fasting VLDL. The linearity of the VLDL increase and the very early
response in the Intralipid-treated rats suggest that enhanced synthesis of
VLDL is not a major cause for the accumulation. Rather, the present data
indicate that a high plasma concentration of a chylomicron-like
triglyceride emulsion competes efficiently with liver- derived VLDL for the
same lipolytic pathway, which leads to accumulation in plasma of endogenous
VLDL in the postprandial state.
ARTICLES
Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway
Atherosclerosis Research Unit, King Gustaf V Research Institute, Stockholm, Sweden.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Magnoni, E. Vaillancourt, and J.-M. Weber High resting triacylglycerol turnover of rainbow trout exceeds the energy requirements of endurance swimming Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R309 - R315. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. R. Al-Shayji, J. M. R. Gill, J. Cooney, S. Siddiqui, and M. J. Caslake Development of a novel method to determine very low density lipoprotein kinetics J. Lipid Res., September 1, 2007; 48(9): 2086 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasunaga, S. Saito, Y.-L. Zhang, A. Hernandez-Ono, and H. N. Ginsberg Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice J. Lipid Res., May 1, 2007; 48(5): 1108 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Oakes, P. Thalen, T. Hultstrand, S. Jacinto, G. Camejo, B. Wallin, and B. Ljung Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R938 - R946. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.H. van Wijk, E. J.P. de Koning, M. Castro Cabezas, and T. J. Rabelink Rosiglitazone Improves Postprandial Triglyceride and Free Fatty Acid Metabolism in Type 2 Diabetes Diabetes Care, April 1, 2005; 28(4): 844 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castro Cabezas, C. Verseyden, S. Meijssen, H. Jansen, and D. W. Erkelens Effects of Atorvastatin on the Clearance of Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5972 - 5980. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, and M. C. Cabezas Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Q. Chang, O. Karatayev, Z. Davydova, and S. F. Leibowitz Circulating Triglycerides Impact on Orexigenic Peptides and Neuronal Activity in Hypothalamus Endocrinology, August 1, 2004; 145(8): 3904 - 3912. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Niu, D. Hauton, and R. D. Evans Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates J. Physiol., July 1, 2004; 558(1): 225 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Sposito, P. A. Lemos, R. D. Santos, W. Hueb, C. G. C. Vinagre, E. Quintella, O. Carneiro, M. J. Chapman, J. A. F. Ramires, and R. C. Maranhao Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: A long-term follow-up study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2225 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia J. Lipid Res., November 1, 2003; 44(11): 2100 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Evans, G. C. Burdge, S. A. Wootton, M. L. Clark, and K. N. Frayn Regulation of Dietary Fatty Acid Entrapment in Subcutaneous Adipose Tissue and Skeletal Muscle Diabetes, September 1, 2002; 51(9): 2684 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, and M. C. Cabezas Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia J. Lipid Res., February 1, 2002; 43(2): 274 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mardy, D. D. Belke, and D. L. Severson Chylomicron metabolism by the isolated perfused mouse heart Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E357 - E364. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Harris, J. E. Gosnell, and Z. L. Kumwenda Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity Innate Immunity, December 1, 2000; 6(6): 421 - 430. [Abstract] [PDF] |
||||
![]() |
S.-Q. Xiang, K. Cianflone, D. Kalant, and A. D. Sniderman Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase J. Lipid Res., September 1, 1999; 40(9): 1655 - 1663. [Abstract] [Full Text] |
||||
![]() |
N. Mero, L. Suurinkeroinen, M. Syvänne, P. Knudsen, H. Yki-Järvinen, and M.-R. Taskinen Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant J. Lipid Res., September 1, 1999; 40(9): 1663 - 1670. [Abstract] [Full Text] |
||||
![]() |
J. R. Burnett, P. H. R. Barrett, P. Vicini, D. B. Miller, D. E. Telford, S. J. Kleinstiver, and M. W. Huff The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1906 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. van Beek, H. H. J. J. van Barlingen, F. C. de Ruijter-Heijstek, H. Jansen, D. W. Erkelens, G. M. Dallinga-Thie, and T. W. A. de Bruin Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity J. Lipid Res., February 1, 1998; 39(2): 322 - 332. [Abstract] [Full Text] |
||||
![]() |
J. Björkegren, F. Karpe, S. Vitols, P. Tornvall, and A. Hamsten Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro J. Lipid Res., February 1, 1998; 39(2): 423 - 437. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |